Inhalation of residual oil fly ash (ROFA), a component of ambient particulate matter, has been shown to increase pulmonary morbidity and impair lung defense mechanisms in exposed workers. Our objective was to evaluate the effect of ROFA preexposure on lung defense and injury after pulmonary challenge with a bacterial pathogen. Male Sprague-Dawley rats were dosed intratracheally at day 0 with saline (control) or ROFA (0.2 or 1 mg/100 g body weight). Three days later, a low (5 ؋ 10 3 ) or high (5 ؋ 10 5 ) dose of Listeria monocytogenes was instilled intratracheally into the ROFA-and saline-treated rats. Bronchoalveolar lavage was performed on the right lungs at days 6, 8, and 10. The recovered cells were differentiated, and chemiluminescence (CL) and nitric oxide (NO) production, two indices of alveolar macrophage (AM) function, were measured. At the same time points, the left lung and spleen were removed, homogenized, and cultured, and colonyforming units were counted after an overnight incubation. Exposure to ROFA and the high dose of L. monocytogenes led to marked lung injury and inflammation as well as to an increase in mortality, compared with rats treated with saline and the high dose of L. monocytogenes. Preexposure to ROFA significantly enhanced injury and delayed the pulmonary clearance of L. monocytogenes at both bacterial doses when compared to the salinetreated control rats. ROFA had no effect on AM CL but caused a significant suppression of AM NO production, as compared to the saline control rats. We have demonstrated that acute exposure to ROFA slowed the pulmonary clearance of L. monocytogenes. The suppression in AM NO production by ROFA pretreatment likely plays an important role. These results suggest that pulmonary exposure to ROFA may alter AM function and lead to increased susceptibility to lung infection in exposed populations.
Epidemiological studies have demonstrated that inhalation of increased levels of particulate air pollution is associated with a decline in lung function, increased respiratory symptoms, and increased morbidity and mortality in susceptible populations (Dockery and Pope, 1994; Pope et al., 1995; Schwartz, 1994) . Residual oil fly ash (ROFA) is an airborne hazard produced by the combustion of fossil fuels. It has been estimated that fly ash contributes more than 2.5 ϫ 10 5 tons to the ambient air particulate matter burden in the United States annually . ROFA is chemically complex and composed of metals, sulfates, acids, fuel contaminants, and other unknown materials combined with an insoluble, particulate carbon core (Ghio et al., 2002) . Occupational exposure to ROFA has been associated with adverse respiratory health effects in humans (Hauser et al., 1995a,b; Levy et al., 1984) . Because of the elemental similarities with ambient air particulate matter and its contribution to air pollution burden, ROFA has been extensively used as a surrogate for studies evaluating the pulmonary responses to particulate matter exposure (Ghio et al., 2002) .
Mechanisms of pulmonary toxicity to ROFA have been suggested from animal studies. The bioavailability of soluble transition metals has been implicated as one mechanism for the pulmonary injury induced by ROFA particles Gavett et al., 1997; Kodavanti et al., 1998) . The production of reactive oxygen species (Dye et al., 1997; Pritchard et al., 1996) , release of inflammatory cytokines (Veronesi et al., 1999) , and alterations in signal transduction (Samet et al., 1996 have also been seen to play important roles in ROFA-induced lung injury. ROFA has been shown to enhance pulmonary infections in mice and to be cytotoxic to alveolar macrophages, AMs (Hatch et al., 1985) . In addition, mortality after intratracheal instillation of ROFA in mice with subsequent bacterial exposure correlated with metal concentrations (Pritchard et al., 1996) . It has been proposed that exposure to ROFA may increase the susceptibility to infection because of transcriptional inhibition of pathogen resistance pathways (Longphre et al., 2000) .
The objective of our study was to examine the effect ROFA has on innate pulmonary defense mechanisms after infection. It is hypothesized that the pulmonary exposure to ROFA may increase the susceptibility to lung infection. Little is known about the effect of co-exposure to ROFA and a bacterial pathogen on respiratory defense function. Further studies using ROFA, in which infections are involved, are needed to address this problem. The gram-positive, facultative intracellular bacterial pathogen, Listeria monocytogenes, has been commonly used to assess pulmonary defense mechanisms (Antonini et al., 2000 (Antonini et al., , 2001a Cohen et al., 2001; Jakab, 1993; Van Loveren et al., 1988) . In the present study, male Sprague-Dawley rats were preexposed to ROFA by intratracheal instillation and then infected with L. monocytogenes. The development of lung injury and inflammation, alterations in AM function, and the effects on the pulmonary clearance of L. monocytogenes after ROFA exposure were assessed.
MATERIALS AND METHODS
Animals. Male Sprague-Dawley rats (Hilltop Laboratories, Scottdale, PA) weighing 250 -300 g were used for all experiments. They were given a conventional laboratory diet and tap water ad libitum, housed in a clean air and viral-and antigen-free room with restricted access, and allowed to acclimate in an AAALAC-approved animal facility for one week before use.
Materials.
Listeria monocytogenes (strain 10403S, serotype 1) was obtained as a gift from Rosana Schafer of the Department of Microbiology and Immunology at West Virginia University. Residual oil fly ash (ROFA) was collected from a precipitator at Boston Edison Co., Mystic Power Plant #4, Everett, MA. Particle size of the ROFA sample was characterized by scanning electron microscopy (JSM-#5600 SEM, JEOL Ltd., Peabody, MA). The ROFA particles were of respirable size with a count mean diameter of 2.2 m. Analysis of the metal constituents of the ROFA sample was determined using inductively coupled argon plasma, atomic-emission spectroscopy (NIOSH, 1994) . The amount of each element per instillate of ROFA is as follows: 244.6 g of Fe, 121.8 g of Al, 92.00 g of V, 76.86 g of Ni, 61.10 g of Ca, and 10.69 g of Zn were present.
Experimental design. At day 0, rats were preexposed by intratracheal instillation of ROFA (0.2 or 1.0 mg/100 g body weight [bw]) or saline (vehicle control). At day 3, the animals were further divided into 3 groups and intratracheally inoculated with saline, 5 ϫ 10 3 L. monocytogenes (low dose), or 5 ϫ 10 5 L. monocytogenes (high dose) as previously described (Antonini et al., 2000) . At days 6, 8, and 10, bronchoalveolar lavage was performed on the right lungs. The cells recovered were differentiated, and chemiluminescence (CL), nitric oxide (NO) production, and phagocytosis were measured as indices of macrophage function. From the same animals, the left lung and spleen were removed, homogenized, and the number of bacteria colonyforming units (CFUs) was determined.
ROFA treatment. ROFA particles were suspended in sterile saline and sonicated for 1 min with a Sonifier 450 Cell Disruptor (Branson Ultrasonics, Danbury, CT). Rats were lightly anesthetized by an intraperitoneal injection of 0.6 ml of a 1% solution of sodium methohexital (Brevital, Eli Lilly, Indianapolis, IN) and intratracheally instilled with 0.2 or 1.0 mg/100 g bw of ROFA in 300 l of saline, according to the method of Brain et al. (1976) . The ROFA concentrations were chosen after a pilot study using this particular ROFA sample to include a dose (1.0 mg/100 g) that induces lung inflammation as well as a dose (0.2 mg/100 g) that does not (Antonini et al., 2002) . In addition, the intratracheal ROFA concentrations used in this study fell within the range of concentrations consistently used in other animal studies evaluating the pulmonary responses to ROFA (Pritchard et al., 1996; Dreher et al., 1997; Gavett et al., 1997; Kodavanti et al., 1998) . Animals in the vehicle control group were intratracheally dosed with 300 l of sterile saline.
Intratracheal bacteria inoculation. L. monocytogenes was cultured overnight in brain heart infusion broth (Difco Laboratories, Detroit, MI) at 37°C in a shaking incubator. Following incubation, the bacteria concentration was determined spectrophotometrically at an optical density of 600 nm and diluted with sterile saline to the desired concentrations.
At 3 days post-ROFA/saline instillation, the rats were inoculated intratracheally with either a low (5 ϫ 10 3 ) or high (5 ϫ 10 5 ) dose of L. monocytogenes in 500 l of sterile saline, according to the instillation method described in the previous section. These two doses were found, in a previous pilot study, to give a uniform infection and not to kill untreated naive Sprague-Dawley rats (Antonini et al., 2001a) . The intratracheal instillation of 5 ϫ 10 3 L. monocytogenes was selected because it did not elicit an inflammatory response in the lungs, whereas the higher 5 ϫ 10 5 L. monocytogenes was observed to induce a significant influx of neutrophils into lungs soon after instillation.
Morbidity/histopathology. Animal weights and morbidity were monitored over the course of the treatment period. Histopathological analysis was performed on the lungs of rats from each group. Rats were euthanized with sodium pentobarbital, and the lungs were preserved with 10% buffered formalin by airway fixation at total lung capacity. The lobes of the lungs were removed, sectioned, embedded in paraffin, and stained with hematoxylin and eosin. Histopathological analysis was performed by Dr. Val Vallyathan (NIOSH, Morgantown, WV) who was unaware of the experimental design and blinded to the treatment groups of the study. Bronchoalveolar lavage. At days 6, 8, or 10, the rats were deeply anesthetized with an overdose of sodium pentobarbital and then exsanguinated by severing the abdominal aorta. The left bronchus was clamped off, and bronchoalveolar lavage (BAL) was performed on the right lungs of rats from each group, as previously described (Antonini et al., 2000) .
Pulmonary clearance of L. monocytogenes. At days 6, 8, and 10, the left lungs and spleens were removed from all rats in each treatment group. The excised tissues were suspended in 10 ml of sterile water, homogenized using a Polytron 2100 homogenizer (Brinkmann Instruments, Westbury, NY), and cultured quantitatively on brain-heart infusion agar plates (Becton Dickinson and Co., Cockeysville, MD). The number of viable CFUs were counted after an overnight incubation at 37°C. Cellular evaluation. Total cell numbers were determined using a Coulter Multisizer II and AccuComp software (Coulter Electronics, Hialeah, FL). Cells were differentiated using a Cytospin 3 centrifuge (Shandon Life Sciences International, Cheshire, England), and 1 ϫ 10 5 cells were spun for 5 min at 800 rpm and pelleted onto a slide. Cells (200/rat) were identified on cytocentrifugeprepared slides after labeling with Leukostat stain (Fisher Scientific, Pittsburgh, PA).
Biochemical parameters of injury. Within the acellular BAL fluid from the first 4 ml of a lavage sample, albumin content, a measure to quantify increased permeability of the bronchoalveolar-capillary barrier and lactate dehydrogenase (LDH) activity, an indicator of general cytotoxicity, were measured. Albumin content was determined colorimetrically at 628 nm based on albumin binding to bromcresol green using an albumin BCG diagnostic kit (Sigma Chemical Company, St. Louis, MO). Measurements were performed with a Cobas Fara II analyzer (Roche Diagnostic Systems, Montclair, NJ). LDH activity was determined by measuring the reduction of pyruvate coupled with the oxidation of NADH at 340 nm. LDH enzyme reagents were purchased from Roche Diagnostics Systems (Indianapolis, IN).
Luminol-dependent chemiluminescence. Luminol-dependent chemiluminescence (CL), a measure of light generation representing reactive oxidant species (ROS) production, was performed with an automated Berthold Autolumat LB 953 luminometer (Wallace, Inc., Gaithersburg, MD) as described previously (Antonini et al., 1994) . Non-opsonized, insoluble zymosan (2 mg/ml; Sigma Chemical Co., St. Louis, MO) was used as a stimulant and was added to the assay immediately prior to measurement of CL. Rat neutrophils have not been shown to respond to unopsonized zymosan in our system, therefore, the zymosan-stimulated CL produced is from AMs. Measurement of CL was recorded for 15 min at 37°C, and the integral of counts per min (cpm) versus time was calculated. CL was calculated as the cpm of stimulated cells minus the cpm of the corresponding resting cells. CL generated from non-stimulated AMs was not significantly different among the different treatment groups.
Alveolar macrophage nitric oxide production. BAL cells were suspended at a concentration of 1 ϫ 10 6 cells/ml in essential minimum eagle medium (EMEM, BioWhittaker, Walkersville, MD) supplemented with 2 mM glutamine, 100 g/ml streptomycin, 100 units/ml penicillin and 10% heat-activated fetal calf serum, and seeded onto each well of a 24-well tissue culture plate. BAL cells were allowed to adhere to the plates for 2 h at 37°C at 5% CO 2 . After the incubation, non-adherent cells were removed by washing 3 times with EMEM medium. The adherent cells, which were found to be Ͼ90% AMs, were then incubated in fresh EMEM for 18 h at 37°C at 5% CO 2 . The AM-conditioned media were collected, centrifuged, and stored at -70°C until analysis. The production of nitric oxide was determined as an accumulation of nitrite by a modified microplate assay using the Griess reagent (Green, 1982) . Briefly, the samples were incubated with an equal volume of the Griess reagent at room temperature for 10 min. The absorbance at 550 nm was determined with a microplate spectrophotometer reader (SpectraMax 250, Molecular Devices Co., Sunnyvale, CA). Sodium nitrite (Sigma Chemical Co., St. Louis, MO) was used as a standard. The results were expressed as nmol nitrite/ 10 6 AMs.
Alveolar macrophage phagocytosis/bactericidal killing. AM phagocytosis and bacterial killing was determined by a method modified from Ohya et al. (1998) . AMs were recovered by BAL from rats 3 days after the intratracheal instillation of ROFA (1 mg/100 g bw) or saline. The recovered AMs from each animal were allowed to attach in 24-well plates for 3 h at 37°C in RPMI-1640 media (Sigma Chemical Co., St. Louis, MO) with 10% fetal bovine serum at a concentration of 5 ϫ 10 5 cells/well. After the incubation period, the wells were washed 4 times with media to remove non-adherent cells. The adherent cells (found to be Ͼ90% AMs) were treated with 1 ϫ 10 7 L. monocytogenes at 37°C for 1.5 h. After this second incubation, one set of AMs from each animal was washed 6 times with media and lysed in distilled H 2 O while sonicating with a Sonifer 450 Cell Disruptor. This first lysate was diluted, cultured overnight at 37°C, and viable CFUs were counted to determine AM phagocytosis. For the remaining AMs from each animal, the cells were incubated for an additional 4 and 18 h at 37°C. The AMs were continually washed every 2 h during the incubation period with media containing 10 g/ml of chloramphenicol (Sigma Chemical Co., St. Louis, MO) to kill any extracellular bacteria that had not been taken up by the AMs after the first incubation. After the incubations, the AMs were lysed, diluted, cultured overnight at 37°C, and the number of viable CFUs counted. The number of bacteria killed by the AMs was determined by subtracting the number of CFUs of the lysates at 4 and 18 h from the number of CFUs from the first lysate at 1.5 h.
AMs from all treatments at each time point were allowed to adhere to glass cover slips and imaged using a Sarastro 2000 laser scanning confocal microscope (Molecular Dynamics, Inc., Sunnyvale, CA). Bacteria were immunolabeled using rabbit anti-L. monocytogenes primary IgG antibody (Biodesign International, Saco, ME) and FITC-labeled goat anti-rabbit secondary IgG antibody (Sigma Chemical Co., St. Louis, MO).
Statistical analysis.
Results are expressed as means Ϯ standard error of measurement (SE). Statistical analyses were carried out with the JMP IN statistical program (SAS, Inc., Belmont, CA). The significance of the interaction among the different treatment groups for the different parameters at each time point was assessed using an analysis of variance (ANOVA). The significance of difference between individual groups was analyzed using the TukeyKramer post hoc test. For all analyses, the criterion of significance was set at p Ͻ 0.05.
RESULTS
Pulmonary clearance of L. monocytogenes. ROFA highand low-dose groups slowed the clearance of L. monocytogenes from the lungs at both bacteria doses (Fig. 1) . A significant elevation in pulmonary bacterial CFUs was observed at day 10 for the group preexposed to the low-dose ROFA before treatment with the low dose of bacteria, whereas significant increases in bacterial CFUs were measured at all time points after treatment with the high dose of L. monocytogenes (Fig. 1A) .
For the lower dose of L. monocytogenes, there were significantly more lung bacterial CFUs counted for the high dose ROFA group at days 6 and 10 as compared to the saline ϩ low dose L. monocytogenes group (Fig. 1B) . For the higher dose of L. monocytogenes, there were significantly more lung bacterial CFUs measured for the high-dose-ROFA group at all three time points as compared to the saline ϩ high dose L. monocytogenes group. At day 10, highly significant increases in bacteria number of 288-and 12-fold were observed for the ROFA high and low L. monocytogenes groups as compared to their respective saline control groups.
Body weight/survival. The percent change in rat bw after the intratracheal inoculation of L. monocytogenes was assessed (Fig. 2) . A significant loss in bw was observed for both the high-and low-dose ROFA groups instilled with the high dose of L. monocytogenes ( Figs. 2A and 2B ). The percent change in bw for the high dose ROFA ϩ high dose L. monocytogenes group continued to decline (Fig. 2B) , whereas the percent change in bw for rats of all other groups had begun to rise by 10 days (Figs. 2A and 2B ). Without infection, the two doses of ROFA caused no change in bw.
All the rats from each of the treatment groups, except for the high-dose ROFA ϩ high-dose L. monocytogenes group, survived for the duration of the experiment period (data not shown). One rat from the high-dose ROFA ϩ high-dose L. monocytogenes group expired within 24 h after intratracheal inoculation of the bacteria. By day 7, 30% of the rats from this group had died.
Histopathology. Histopathological analyses were performed on the lungs of each treatment group at day 6 (Fig. 3) . Lungs appeared normal for the saline ϩ low dose L. monocytogenes group (Fig. 3A) . A mild pneumonitis, characterized by a peribronchiolar accumulation of neutrophils, and some particle accumulation were observed in the terminal bronchiolar regions of the lungs in the high dose ROFA ϩ low dose L. monocytogenes group (Fig. 3C) . At a higher magnification, particle-containing macrophages were observed throughout the alveolar region for the high dose ROFA ϩ low dose L. monocytogenes group (Fig. 3E, arrowheads) . For the saline or high dose ROFA groups treated with the high dose of L. monocytogenes, edema, inflammation with significant infiltration of neutrophils, and many granulomatous lesions with amorphous tissue debris were observed (Figs. 3B and 3D ). The lesions that were observed in the high-dose ROFA ϩ high-dose L. monocytogenes were much more extensive and significantly more pronounced than those observed in the saline ϩ high-dose L. monocytogenes. Several areas of particle accumulation were observed in the lungs of the high-dose ROFA ϩ high-dose L. monocytogenes group (Figs. 3D and 3F, arrows) .
Bronchoalveolar lavage fluid injury and inflammation parameters.
Two indicators of lung damage (albumin content and LDH activity) were assessed within the recovered BAL fluid (Table 1) . At day 3, ROFA treatment (1.0 mg/100 g bw) caused significant elevations in albumin and LDH as compared to its corresponding saline control. In the animals that received a second instillation of saline on day 3, high-dose ROFA pretreatment caused a significant increase in albumin at day 6 and in LDH at all three time points, as compared to the saline ϩ saline group. Intratracheal inoculation of the low dose of L. monocytogenes to rats pretreated with saline had no effect on either of the BAL indices at any of the time points postbacterial treatment to the saline ϩ saline control. Pulmonary instillation of the low dose of L. monocytogenes to ROFApretreated rats caused significant elevations in both parameters at various time points as compared to the saline ϩ saline group. By day 10, only the LDH values were elevated in the ROFApretreated animals.
Intratracheal inoculation of the high dose of L. monocytogenes to rats pretreated with saline caused significant increases in both parameters as compared to the saline ϩ saline control at days 6 and 8. A significant elevation in LDH was observed at day 10. Both indices of lung damage were elevated in the rats treated with high-dose ROFA and the high dose of L. monocytogenes as compared to the saline ϩ saline group at all three time points. At day 10, LDH was significantly elevated in the high-dose ROFA ϩ high dose L. monocytogenes group when compared with the saline ϩ high dose L. monocytogenes group. In the assessment of the cellular response, the number of AMs and neutrophils was determined after BAL (Fig. 4) . No significant differences were observed among any of the groups in the number of AMs recovered at days 3, 6, and 8 (Fig. 4A) . By day 10, significantly more AMs were recovered from the ROFA and saline groups treated with the high dose of L. monocytogenes as compared to the groups that were not treated with the bacteria. A significant elevation in neutrophil number was observed for the high-dose ROFA ϩ saline group as compared to its respective saline control at each time point (Fig. 4B) . The two groups that were inoculated with the high dose of bacteria had significant increases in neutrophil number as compared to the non-bacteria groups. At day 10, the high dose ROFA ϩ high dose L. monocytogenes group had a significant elevation in neutrophil number as compared to the saline ϩ high bacteria group, which returned to control levels.
Alveolar macrophage function. The generation of ROS was assessed by measuring the CL of recovered BAL cells (Fig. 5) . In the analysis of non-opsonized, zymosan-stimulated CL, a measure of ROS production by AMs, there was no significant difference between the saline ϩ saline and highdose ROFA ϩ saline groups at any of the time points after instillation of the bacteria (Fig. 5A) . The intratracheal inoculation of the high dose of L. monocytogenes significantly increased zymosan-stimulated CL at days 6 and 8. Preexposure to high dose ROFA had no effect on the zymosan-stimulated CL after inoculation with L. monocytogenes.
The production of NO, another measure of AM function, was determined (Fig. 5B) . AM NO production was significantly reduced in the high-dose ROFA ϩ saline group as compared to the saline ϩ saline group at all three time points. The intratracheal inoculation of the high dose of L. monocytogenes significantly enhanced AM NO production at each time point after bacteria treatment. However, high dose ROFA preexposure significantly suppressed the bacteria-induced elevation in AM NO production at all three time points post-L. monocytogenes inoculation.
The phagocytic and bacterial killing activities of AMs recovered from rats intratracheally instilled with saline or high dose ROFA were compared ( Fig. 6; Table 2 ). A significant increase of 3.7-fold was observed in the uptake of the L. monocytogenes at 1.5 h by the AMs recovered from the ROFA group as compared with the saline group. There were 6.5-and 8-fold increases in the number of bacteria present in the AMs of the ROFA animals as compared to the AMs of the saline animals at 4 and 18 h, respectively. These elevations in the numbers of intracellular bacteria for the high dose ROFA group were easily observed microscopically at each time point (Fig. 6) . A significant decrease in the percentage of bacteria killed was determined for the AMs collected from the ROFA group at 4 and 18 h as compared to the AMs from the saline group.
DISCUSSION
It has been suggested that inhaled particulate matter may exacerbate preexisting health conditions (Dockery and Pope, 1994) and augment pulmonary infection (Schwartz, 1994) .
Animal studies have demonstrated that a significant component of particulate matter, ROFA, is highly toxic to the lungs Kodavanti et al., 1998) . ROFA exposure has been shown to affect lung defense responses in laboratory animals (Hatch et al., 1985; Longphre et al., 2000; Pritchard et al., 1996) . However, mechanisms for these altered lung responses are not well characterized. The goals of this current investigation were to (1) assess whether preexposure of rats to ROFA before intratracheal inoculation with a bacterial pathogen suppresses non-specific local pulmonary defense function and (2) identify potential mechanisms by which rats preexposed to ROFA may be more susceptible to pulmonary infection.
Intratracheal instillation of ROFA to laboratory animals induces lung injury and inflammation Kodavanti et al., 1998) . This pneumotoxic response was shown to be dose-dependent and transient, declining by 96 h after exposure. In our current study, we also observed an acute lung response in rats dosed intratracheally with ROFA that was characterized by neutrophilia and in vivo cytotoxicity that subsided over time. In addition, we found that the clearance of the bacteria from the lungs of rats preexposed to ROFA was dramatically slowed after intratracheal inoculation with either a non-inflammatory or a highly inflammatory dose of L. monocytogenes. In comparing ROFA treatment without bacteria to ROFA ϩ the low L. monocytogenes dose, only slight differences were observed in lung damage with no effect on animal survival. However, a significant loss in bw and a substantial increase in morbidity were observed in the rats preexposed to ROFA and then infected with the high dose of L. monocytogenes. Severe edema, a dramatic infiltration of neutrophils, and massive pulmonary infection were observed in the ROFAexposed rats that had expired. Are the injury and inflammation induced by ROFA then responsible for increasing the susceptibility of the lungs to infection?
In earlier studies, an excess mortality was observed in mice instilled intratracheally with ROFA prior to exposure to aerosolized Streptococcus (Hatch et al., 1985; Pritchard et al., 1996) . Hatch et al. (1985) observed the ROFA particles to be highly cytotoxic to AMs. However, in the assessment of other particulate samples, not all the particles that were highly cytotoxic to AMs caused elevations in bacterial infectivity. Corroborating this work, we have shown previously that the pulmonary clearance of L. monocytogenes was actually enhanced in inflamed and fibrotic lungs of animals treated with the highly cytotoxic mineral particle, crystalline silica, thus indicating that significant lung injury may not play a significant role in affecting lung defense after concomitant exposure to particulates and bacteria (Antonini et al., 2000) . It was observed instead that acute exposure to high doses of silica enhanced lung defense mechanisms by activating AMs and increasing phagocytosis and the production of reactive oxygen species.
In a related infectivity study, Van Loveren et al. (1988) have shown that inhalation of ozone decreases the clearance of L. monocytogenes from the lungs, concluding that this was most likely due to a suppression of AM activity. Ozone exposure was observed to significantly decrease AM phagocytosis of L. monocytogenes. Previously, we observed that pretreatment with diesel exhaust particles enhanced the pulmonary infection of L. monocytogenes (Yang et al., 2001) . This elevation in infection was accompanied by a decrease in the pulmonary clearance of the bacteria likely do to alterations in AM function. Yang et al. (1997) have shown the responses of AMs treated with diesel exhaust particles to be suppressed after stimulation with lipopolysaccharide, likely increasing the susceptibility of the lungs to infection after diesel exposure. In addition, susceptible populations may be at increased risk for lung infections. We have shown that advanced age is associated with decrements in lung defense and altered AM function in rats after L. monocytogenes exposure (Antonini et al., 2001b) .
Interestingly, ROFA pretreatment had no effect on the generation of reactive oxygen species as measured by CL before and after infection with L. monocytogenes. However, CL is a non-specific measure of the light emitted from activated phagocytic cells that accompanies the release of various forms of reactive oxidant species. In studying the modulator effect of ozone on the pulmonary clearance of L. monocytogenes, Cohen et al. (2001) observed specifically that hydrogen peroxide production by AMs was significantly reduced after ozone exposure. North et al. (1997) an important role in AM-mediated defense against infections, was measured specifically in our current study.
The production of NO was significantly suppressed in AMs recovered from non-infected and infected animals that were preexposed to ROFA. NO has been shown to promote the cytotoxic activities of AMs and modulate cell-mediated immunity (Lyons, 1995; Nathan and Xie, 1994) . NO combines with the reactive oxygen intermediate, superoxide anion, to form the highly reactive substance, peroxynitrite (Pryor and Squadrito, 1995) . Hickman-Davis et al. (1999) have demonstrated that peroxynitrite generation by AMs is an important mechanism in the killing of bacterial pathogens in the lungs. In addition, we have shown that AMs from aged rats produced less NO than AMs from young adult rats, this increasing the older rats' susceptibility to infection (Antonini et al., 2001b ).
In our current study, a significant suppression in the percentage of bacteria killed by AMs recovered from ROFA-treated animals was observed, even though AM phagocytosis was increased. The suppression in pulmonary clearance of the bacteria that we observed might possibly be explained by the decrease in NO production by AMs recovered from rats exposed to ROFA before the L. monocytogenes challenge. Ohya et al. (1998) have indicated that reactive oxygen species play a significant role in Listericidal activity only if AMs are activated prior to infection. If the AMs ability to respond to bacteria challenge is suppressed, as we observed with ROFA, reactive nitrogen intermediates such as NO may be involved in the intracellular macrophage killing.
Additional in vitro AM studies utilizing antioxidants, inhibitors of reactive oxygen and reactive nitrogen intermediates, and other components of the lung defense system such as surfactant protein A are ongoing in our laboratory to further evaluate the mechanisms by which ROFA may increase the susceptibility to lung infection. Also, numerous animal studies have suggested that the metal components of ROFA are the major determinants of their potential to induce pulmonary injury and inflammation (Gavett et al., 1997; Kodavanti et al., 1998) . Dreher et al. (1997) have provided evidence for the toxic role of soluble metals in acute pulmonary injury induced by ROFA. Goldsmith et al. (1998) demonstrated that the watersoluble components of ROFA alter AM function by significantly increasing their respiratory burst. Thus, additional in vivo studies are needed to assess what components of ROFA may potentially alter defense mechanisms of the lungs. Currently, rat infectivity studies are being conducted in our laboratory, evaluating the role by which the soluble metals of ROFA may alter lung infection susceptibility. Preliminary results indicate that the soluble fraction of ROFA increases mortality and slows the pulmonary clearance of L. monocytogenes .
In summary, the present study demonstrated that rats preexposed to ROFA have altered lung defenses, making them more susceptible to lung injury, inflammation, and infection after bacterial challenge. In ROFA-treated animals, we observed a dramatic alteration in the pulmonary clearance of a bacterial pathogen along with a reduction in NO production by AMs. Thus, exposure to ROFA in the workplace or from air pollution may suppress the lung's ability to defend against infection. 
